Name: Rani Therapeutics Holdings, Inc. (RANI) Financial Statements
Creator: FinSpry

Rani Therapeutics Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Rani Therapeutics Holdings, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	1.03	0.00	0.00	2.72	0.46
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	1.03	0.00	0.00	2.72	0.46
Operating Expenses
Research & Development	26.68	39.62	36.61	26.48	12.04
Selling, General & Administrative	23.95	26.48	26.84	27.83	4.96
Operating Expenses	54.34	66.10	63.45	54.32	17.01
Operating Income	-53.31	-66.10	-63.45	-51.60	-16.54
Other Income/Expense
Interest Income	1.76	3.30	1.25	0.09	0.06
Interest Expense	5.03	-5.09	1.07	-0.47	-0.12
Other Income/Expense	23.30	0.00	0.00	-0.37	-0.06
Income
Income Before Tax	-30.02	-67.88	-63.27	-53.05	-16.67
Income Tax Expense	26.57	0.00	0.07	0.04	0.04
Net Income	-30.02	-33.97	-30.59	-8.33	0.00
Net Income - Continuous Operations	-30.02	-67.88	-63.34	-53.09	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-50.52	-61.98	-61.66	-51.10	-15.96
EBIT	-49.60	-62.80	-62.20	-51.60	-16.54
Depreciation & Amortization	1.03	0.80	0.50	0.50	0.59
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	-	-
Diluted EPS	-1.00	-1.00	-1.00	-	-
Basic Shares Outstanding	28.48	0.03	0.02	19.53	46.89
Diluted Shares Outstanding	28.48	0.03	0.02	19.53	46.89